The effects of elafibranor in people with primary biliary cholangitis: a plain language summary
Loading...
Date
2025
Journal Title
Journal ISSN
Volume Title
Publisher
Taylor and Francis Ltd.
Abstract
This is a plain language summary describing the phase 3 clinical trialcalled ‘ELATIVE®’. Primary biliary cholangitis (PBC) is a rare disease of the liverthat can get worse over time and can be potentially life threatening. Livingwith PBC can also reduce a person’s quality of life. There are currently notmany treatment options available for PBC. The ELATIVE® clinical trial testedhow well a potential new treatment called ‘elafibranor’ works in treatingpeople with PBC.